vs
Side-by-side financial comparison of ENANTA PHARMACEUTICALS INC (ENTA) and UNITY BANCORP INC (UNTY). Click either name above to swap in a different company.
UNITY BANCORP INC is the larger business by last-quarter revenue ($35.3M vs $18.6M, roughly 1.9× ENANTA PHARMACEUTICALS INC). UNITY BANCORP INC runs the higher net margin — 43.9% vs -64.1%, a 108.0% gap on every dollar of revenue. On growth, UNITY BANCORP INC posted the faster year-over-year revenue change (24.2% vs 9.8%). UNITY BANCORP INC produced more free cash flow last quarter ($44.3M vs $-11.8M). Over the past eight quarters, UNITY BANCORP INC's revenue compounded faster (17.5% CAGR vs 4.5%).
Enanta Pharmaceuticals Inc is a clinical-stage biotechnology company that develops innovative antiviral therapies for infectious diseases including hepatitis B virus, respiratory syncytial virus (RSV), and SARS-CoV-2. It operates primarily in the U.S. and global markets, partnering with pharmaceutical firms to advance its small molecule drug candidate pipeline for patients with unmet medical needs.
Unity Bancorp Inc is a New Jersey-headquartered financial holding company operating Unity Bank. It offers a full range of commercial and retail banking services including business loans, deposit products, mortgage services, and personal banking solutions, primarily serving small and medium-sized enterprises and individual consumers across local communities in New Jersey and eastern Pennsylvania.
ENTA vs UNTY — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.6M | $35.3M |
| Net Profit | $-11.9M | $15.5M |
| Gross Margin | — | — |
| Operating Margin | -60.5% | 55.8% |
| Net Margin | -64.1% | 43.9% |
| Revenue YoY | 9.8% | 24.2% |
| Net Profit YoY | 46.4% | 34.5% |
| EPS (diluted) | $-0.42 | $1.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.6M | $35.3M | ||
| Q3 25 | $15.1M | $32.8M | ||
| Q2 25 | $18.3M | $34.4M | ||
| Q1 25 | $14.9M | $29.4M | ||
| Q4 24 | $17.0M | $28.4M | ||
| Q3 24 | $14.6M | $27.7M | ||
| Q2 24 | $18.0M | $25.5M | ||
| Q1 24 | $17.1M | $25.6M |
| Q4 25 | $-11.9M | $15.5M | ||
| Q3 25 | $-18.7M | $14.4M | ||
| Q2 25 | $-18.3M | $16.5M | ||
| Q1 25 | $-22.6M | $11.6M | ||
| Q4 24 | $-22.3M | $11.5M | ||
| Q3 24 | $-28.8M | $10.9M | ||
| Q2 24 | $-22.7M | $9.5M | ||
| Q1 24 | $-31.2M | $9.6M |
| Q4 25 | -60.5% | 55.8% | ||
| Q3 25 | -121.6% | 57.5% | ||
| Q2 25 | -103.2% | 62.6% | ||
| Q1 25 | -164.3% | 52.6% | ||
| Q4 24 | -138.8% | 51.0% | ||
| Q3 24 | -204.4% | 52.7% | ||
| Q2 24 | -134.6% | 49.3% | ||
| Q1 24 | -192.1% | 50.0% |
| Q4 25 | -64.1% | 43.9% | ||
| Q3 25 | -123.6% | 43.8% | ||
| Q2 25 | -99.7% | 48.0% | ||
| Q1 25 | -151.7% | 39.5% | ||
| Q4 24 | -131.4% | 40.5% | ||
| Q3 24 | -197.3% | 39.4% | ||
| Q2 24 | -126.1% | 37.1% | ||
| Q1 24 | -182.7% | 37.5% |
| Q4 25 | $-0.42 | $1.52 | ||
| Q3 25 | $-0.88 | $1.41 | ||
| Q2 25 | $-0.85 | $1.61 | ||
| Q1 25 | $-1.06 | $1.13 | ||
| Q4 24 | $-1.05 | $1.13 | ||
| Q3 24 | $-1.36 | $1.07 | ||
| Q2 24 | $-1.07 | $0.92 | ||
| Q1 24 | $-1.47 | $0.94 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $37.4M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $126.6M | $345.6M |
| Total Assets | $329.5M | $3.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $37.4M | — | ||
| Q3 25 | $32.3M | — | ||
| Q2 25 | $44.8M | — | ||
| Q1 25 | $60.2M | — | ||
| Q4 24 | $84.3M | — | ||
| Q3 24 | $37.2M | — | ||
| Q2 24 | $35.8M | — | ||
| Q1 24 | $63.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $230.8M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $126.6M | $345.6M | ||
| Q3 25 | $64.7M | $334.0M | ||
| Q2 25 | $79.3M | $319.8M | ||
| Q1 25 | $93.5M | $306.1M | ||
| Q4 24 | $111.8M | $295.6M | ||
| Q3 24 | $128.8M | $284.3M | ||
| Q2 24 | $148.9M | $273.4M | ||
| Q1 24 | $166.1M | $266.8M |
| Q4 25 | $329.5M | $3.0B | ||
| Q3 25 | $280.7M | $2.9B | ||
| Q2 25 | $301.0M | $2.9B | ||
| Q1 25 | $323.0M | $2.8B | ||
| Q4 24 | $348.6M | $2.7B | ||
| Q3 24 | $376.7M | $2.6B | ||
| Q2 24 | $398.8M | $2.6B | ||
| Q1 24 | $413.6M | $2.6B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-11.7M | $44.9M |
| Free Cash FlowOCF − Capex | $-11.8M | $44.3M |
| FCF MarginFCF / Revenue | -63.6% | 125.7% |
| Capex IntensityCapex / Revenue | 0.8% | 1.6% |
| Cash ConversionOCF / Net Profit | — | 2.90× |
| TTM Free Cash FlowTrailing 4 quarters | $-18.5M | $81.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-11.7M | $44.9M | ||
| Q3 25 | $-6.5M | $45.5M | ||
| Q2 25 | $17.5M | $-25.3M | ||
| Q1 25 | $-13.5M | $17.9M | ||
| Q4 24 | $-16.8M | $48.0M | ||
| Q3 24 | $-10.4M | $17.7M | ||
| Q2 24 | $-14.8M | $-8.4M | ||
| Q1 24 | $-28.6M | $15.8M |
| Q4 25 | $-11.8M | $44.3M | ||
| Q3 25 | $-7.9M | $45.3M | ||
| Q2 25 | $17.4M | $-25.5M | ||
| Q1 25 | $-16.0M | $17.6M | ||
| Q4 24 | $-25.5M | $47.3M | ||
| Q3 24 | $-19.4M | $17.5M | ||
| Q2 24 | $-21.3M | $-8.6M | ||
| Q1 24 | $-30.3M | $15.7M |
| Q4 25 | -63.6% | 125.7% | ||
| Q3 25 | -52.5% | 138.1% | ||
| Q2 25 | 94.7% | -74.2% | ||
| Q1 25 | -107.4% | 59.9% | ||
| Q4 24 | -150.6% | 166.5% | ||
| Q3 24 | -132.5% | 63.3% | ||
| Q2 24 | -118.6% | -33.7% | ||
| Q1 24 | -177.5% | 61.4% |
| Q4 25 | 0.8% | 1.6% | ||
| Q3 25 | 9.6% | 0.7% | ||
| Q2 25 | 0.8% | 0.5% | ||
| Q1 25 | 17.0% | 1.0% | ||
| Q4 24 | 51.6% | 2.4% | ||
| Q3 24 | 61.3% | 0.5% | ||
| Q2 24 | 36.4% | 0.5% | ||
| Q1 24 | 9.8% | 0.3% |
| Q4 25 | — | 2.90× | ||
| Q3 25 | — | 3.16× | ||
| Q2 25 | — | -1.54× | ||
| Q1 25 | — | 1.54× | ||
| Q4 24 | — | 4.17× | ||
| Q3 24 | — | 1.62× | ||
| Q2 24 | — | -0.89× | ||
| Q1 24 | — | 1.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
